Human parvoviruses B19, PARV4 and bocavirus in pediatric patients with allogeneic hematopoietic SCT

Bone Marrow Transplantation

Volumn 48, Issue 10, 2013, Pages 1308-1312

  Rahiala, J ^a,b   Koskenvuo, M ^a,c   Norja, P ^d   Meriluoto, M ^d   Toppinen, M ^d   Lahtinen, A ^d   Vaisanen E ^d   Waris, M ^c   Vuorinen, T ^c   Saarinen Pihkala, U ^a   Lappalainen, M ^e   Allander, T ^f   Ruuskanen, O ^c   Hedman, K ^d,e   Soderlund Venermo M ^d   Vettenranta, K ^g  

^a UNIVERSITY OF HELSINKI AND HELSINKI UNIVERSITY HOSPITAL   (Finland)

^b Porvoo Hospital   (Finland)

^c UNIVERSITY OF TURKU   (Finland)

^d UNIVERSITY OF HELSINKI   (Finland)

^e HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^f KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^g TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

Author keywords

bocavirus; childhood; hematopoietic SCT; parvovirus 4; parvovirus B19V

Indexed keywords

VIRUS DNA;

ACUTE MYELOMONOCYTIC LEUKEMIA; ADOLESCENT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ANEMIA; ARTICLE; BOCAVIRUS; BOCAVIRUS INFECTION; CHILD; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA SEQUENCE; FEMALE; FEVER; GENOTYPE; GRAFT VERSUS HOST REACTION; HUMAN; HUMAN PARVOVIRUS B19; HUMAN PARVOVIRUS B19 INFECTION; IMMUNOCOMPROMISED PATIENT; INFECTION SENSITIVITY; MAJOR CLINICAL STUDY; MALE; MYELODYSPLASTIC SYNDROME; NEUTROPENIA; NUCLEOTIDE SEQUENCE; PARVOVIRUS; PARVOVIRUS 4 INFECTION; PARVOVIRUS INFECTION; PRESCHOOL CHILD; PRIORITY JOURNAL; RASH; REAL TIME POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDY; SCHOOL CHILD; THROMBOCYTOPENIA; TIME TO TREATMENT; UNRELATED DONORS; VIREMIA; VIRUS GENE; VIRUS LOAD;

ADOLESCENT; BOCAVIRUS; CHILD; CHILD, PRESCHOOL; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INFANT; INFANT, NEWBORN; MALE; PARVOVIRIDAE INFECTIONS; PARVOVIRUS B19, HUMAN; RETROSPECTIVE STUDIES; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS;

EID: 84885574455     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2013.63     Document Type: Article

References (68)

1. Fisher SA. Emerging viruses in transplantation; there is more to infection after transplant than CMV and EBV. Transplantation 2008; 86: 1327-1339.
2. Chatzidimitriou D, Gavriilaki E, Sakellari I, Diza E. Hematopoietic cell transplantation and emerging viral infections. J Med Virol 2010; 82: 528-538.
3. Renaud C, Campbell AP. Changing epidemiology of respiratory viral infections in hematopoietic cell transplant recipients and solid organ transplant recipients. Curr Opin Infect Dis 2011; 24: 333-343.
4. Young NS, Brown KE. Parvovirus B19. N Engl J Med 2004; 350: 586-597.
5. Allander TM, Tammi T, Eriksson M, Bjerkner A, Tiveljung-Lindall A, Andersson B. Cloning of a human parvovirus by molecular screening of respiratory tract samples. Proc Natl Acad Sci USA 2005; 102: 12891-12896. (Pubitemid 41279460)
6. Jones MS, Kapoor A, Lukashov VV, Simmonds P, Hecht F, Delwart E. New DNA viruses identified in patients with acute viral infection syndrome. J Virol 2005; 79: 8230-8236. (Pubitemid 40853526)
7. Servant A, Laperche S, Lallemand F, Marinho V, De Saint Maur G, Meritet JF et al. Genetic diversity within human erythroviruses: identification of three genotypes. J Virol 2002; 76: 9124-9134. (Pubitemid 34919871)
8. Norja P, Hokynar K, Aaltonen LM, Chen R, Ranki A, Partio EK et al. Bioportfolio: lifelong persistence of variant and prototypic erythrovirus DNA genomes in human tissue. Proc Natl Acad Sci USA 2006; 103: 7450-7453. (Pubitemid 43727853)
9. Allain JP, Stramer SL, Carneiro-Proietti ABF, Martins ML, Lopes da Silva SN, Proietti FA et al. Transfusion-transmitted infectious diseases. Biologicals 2009; 37: 71-77.
10. Beske F, Modrow S, Sö rensen J, Schmidt H, Kriener S, Allwinn R et al. Parvovirus B19 pneumonia in a child undergoing allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 2007; 40: 89-91. (Pubitemid 47018420)
11. Klumpen H-J, Petersen EJ, Verdonck LF. Severe multiorgan failure after parvovirus B19 infection in an allogeneic stem cell transplant recipient. Bone Marrow Transplant 2004; 34: 469-470. (Pubitemid 39232380)
12. Muetherig A, Christopeit M, Muller LP, Grothe W, Weber T, Theurich S et al. Human parvovirus B19 infection with GvHD-like erythema in two allogeneic stem cell transplant recipients. Bone Marrow Transplant 2007; 39: 315-316. (Pubitemid 46322641)
13. Broliden K. Parvovirus B19 infection in pediatric solid-organ and bone marrow transplantation. Pediatr Transplant 2001; 5: 320-330. (Pubitemid 32834798)
14. Broliden K, Tolfvenstam T, Norbeck O. Clinical aspects of parvovirus B19 infection. J Intern Med 2006; 260: 285-304. (Pubitemid 44370903)
15. Lindblom A, Heyman M, Gustafsson I, Norbeck O, Kaldensjö T, Vernby A et al. Parvovirus B19 infection in children with acute lymphoblastic leukemia is associated with cytopenia resulting in prolonged interruptions of chemotherapy. Clin Infect Dis 2008; 46: 528-536. (Pubitemid 351263490)
16. Calvo C, Garcia-Garcia ML, Pozo F, Carvajal O, Perez-Brena P, Casas I. Clinical characteristics of human bocavirus infections compared with other respiratory viruses in Spanish children. Pediatr Infect Dis J 2008; 27: 677-680.
17. Pozo F, Garc?á-Garc?á ML, Calvo C, Cuesta I, Pérez-Bren a P, Casas I. High incidence of human bocavirus infection in children in Spain. J Clin Virol 2007; 40: 224-228. (Pubitemid 47552927)
18. Franz A, Adams O, Willems R, Bonzel L, Neuhausen N, Schweizer-Krantz S et al. Correlation of viral load of respiratory pathogens and co-infections with disease severity in children hospitalized for lower respiratory tract infection. J Clin Virol 2010; 48: 239-245.
19. Christensen A, Nordbø SA, Krokstad S, Rognlien AG, Døllner H. Human bocavirus commonly involved in multiple viral airway infections. J Clin Virol 2008; 41: 34-37. (Pubitemid 50012232)
20. Allander T, Jartti T, Gupta S, Niesters HG, Lehtinen P, Osterback R et al. Human bocavirus and acute wheezing in children. Clin Infect Dis 2007; 44: 904-910. (Pubitemid 46452052)
21. Wang K, Wang W, Yan H, Ren P, Zhang J, Shen J et al. Correlation between bocavirus infection and humoral response, and co-infection with other respiratory viruses in children with acute respiratory infection. J Clin Virol 2010; 47: 148-155.
22. Jartti T, Hedman K, Jartti L, Ruuskanen O, Allander T, Sö derlund-Venermo M. Human bocavirus-the first 5 years. Rev Med Virol 2012; 22: 46-64.
23. Longtin J, Bastien M, Gilca R, Leblanc E, de Serres G, Bergelon MG et al. Human bocavirus infections in hospitalized children and adults. Emerg Infect Dis 2008; 14: 217-221. (Pubitemid 351213670)
24. Martin ET, Fairhok MP, Kuypers J, Magaret A, Zerr DM, Wald A et al. Frequent and prolonged shedding of bocavirus in young children attending daycare. J Infect Dis 2010; 201: 1625-1632.
25. Lindner J, Karalar L, Zehentmeier S, Plentz A, Pfister H, Struffet W et al. Humoral immune response against human bocavirus VP2 virus-like particles. Viral Immunol 2008; 21: 443-449.
26. Christensen A, Nordbø SA, Krokstad S, Rognlien AG, Døllner H. Human bocavirus in children: mono-detection, high viral load and viraemia are associated with respiratory tract infection. J Clin Virol 2010; 49: 158-162.
27. Sö derlund-Venermo M, Lahtinen A, Jartti T, Hedman L, Kemppainen K, Lehtinen P et al. Clinical assessment and improved diagnosis of bocavirus-induced wheezing in children, Finland. Emerg Infect Dis 2009; 15: 1423-1430.
28. Karalar L, Lindner J, Schimanski S, Kertai M, Segerer H, Modrow S. Prevalence and clinical aspects of human bocavirus infection in children. Clin Microbiol Infect 2010; 16: 633-639.
29. Tozer SJ, Stephen BL, Whiley DM, Bialasiewicz S, Lyon MJ, Nissen MD et al. Detection of human bocavirus in respiratory, fecal, and blood samples by realtime PCR. J Med Virol 2009; 81: 488-493.
30. De Vries JJC, Bredius RGM, van Rheenen PF, Smiers FJW, Schö lvinck EH, Vossen ACTM et al. Human bocavirus in an immunocompromised child presenting with severe diarrhea. J Clin Microbiol 2009; 4: 1241-1243.
31. Kainulainen K, Waris M, Sö derlund-Venermo M, Allander T, Hedman K, Ruuskanen O. Hepatitis and human bocavirus primary infection in a child with T-cell deficiency. J Clin Microbiol 2008; 12: 4104-4105.
32. Koskenvuo M, Mö ttönen M, Waris M, Allander T, Salmi TT, Ruuskanen O. Human bocavirus in children with acute lymphoblastic leukemia. Eur J Pediatr 2008; 167: 1011-1015.
33. Schenk T, Strahm B, Kontny U, Hufnagel M, Neumann-Haefelin D, Falcone V. Disseminated bocavirus infection after stem cell transplant. Emerg Infect Dis 2007; 9: 1425-1427. (Pubitemid 47510320)
34. Fryer JF, Delwart E, Bernardin F, Tuke PW, Lukashov VV, Baylis SA. Analysis of two human parvovirus PARV4 genotypes identified in human plasma for fractionation. J Gen Virol 2007; 88: 2162-2167. (Pubitemid 47194211)
35. Panning M, Kobbe R, Vollbach S, Drexler JF, Adjei S, Adjei O et al. Novel human parvovirus 4 genotype 3 in infants, Ghana. Emerg Infect Dis 2010; 16: 1143-1146.
36. Simmonds P, Douglas J, Bestetti G, Longhi E, Antinori S, Parravicini C et al. A third genotype of the human parvovirus PARV4 in sub-Saharan Africa. J Gen Virol 2008; 89: 2299-2302.
37. Manning A, Willey SJ, Bell JE, Simmonds P. Comparison of tissue distribution, persistence, and molecular epidemiology of parvovirus B19 and novel human parvoviruses PARV4 and human bocavirus. J Infect Dis 2007; 195: 1345-1352. (Pubitemid 46649622)
38. Longhi E, Bestetti G, Acquaviva V, Foschi A, Piolini R, Meroni L. Human parvovirus in the bone marrow of Italian patients with AIDS. AIDS 2007; 21: 1481-1483. (Pubitemid 46988010)
39. Schneider B, Fryer JF, Reber U, Fischer HP, Tolba RH, Baylis SA et al. Persistence of novel human parvovirus PARV4 in liver tissue of adults. J Med Virol 2008; 80: 345-351.
40. Botto S, Bergallo M, Sidoti F, Terlizzi ME, Astegiano S, Ponti R et al. Detection of PARV4, genotypes 1 and 2, in healthy and pathological clinical specimens. New Microbiol 2009; 32: 189-192.
41. Corcioli F, Zakrzewska K, Fanci R, De Giorgi V, Innocenti M, Rotellini M et al. Human PARV4 DNA in tissues from adult individuals: a comparison with human parvovirus B19 (B19V). Virol J 2011; 7: 272-276.
42. Sharp CP, Lail A, Donfield S, Simmons R, Leen C, Klenerman P et al. High frequencies of exposure to the novel human parvovirus PARV4 in hemophiliacs and injection drug users, as detected by a serological assay for PARV4 antibodies. J Infect Dis 2009; 200: 1119-1125.
43. Simmonds P, Manning A, Kenneil R, Carnie FW, Bell JE. Parenteral transmission of the novel human parvovirus PARV4. Emerg Infect Dis 2007; 13: 1386-1388. (Pubitemid 47510307)
44. Lahtinen A, Kivelä P, Hedman L, Kumar A, Kantele A, Lappalainen M et al. Serodiagnosis of primary infections with human parvovirus 4, Finland. Emerg Infect Dis 2011; 1: 79-82.
45. Yu X, Zhang J, Hong L, Wang J, Yuan Z, Zhang X et al. High prevalence of human parvovirus 4 infection in HBV and HCV infected individuals in Shanghai. PLoS One 2012; 7(1): e29474.
46. Vallerini D, Barozzi P, Quadrelli C, Bosco R, Potenza L, Riva G et al. Parvoviruses in blood donors and transplant patients, Italy. Emerg Infect Dis 2008; 14: 185-186.
47. Tolfvenstam T, Norbeck O, Ohrmalm L. No evidence of presence of parvovirus 4 in a Swedish cohort of severely immunocompromised children and adults. PLoS One 2012; 7(9): e46430.
48. Jartti T, Sö derlund-Venermo M, Hedman K, Ruuskanen O, Mäkelä M. New molecular virus detection methods and their clinical value in lower respiratory tract infections in children. Paediatr Respir Rev 2013; 14: 38-45.
49. Sö derlund M, von Essen R, Haapasaari J, Kiistala U, Kiviluoto O, Hedman K. Persistence of parvovirus B19 DNA in synovial membranes of young patients with and without chronic arthropathy. Lancet 1997; 349: 1063-1065. (Pubitemid 27158252)
50. Hokynar K, Norja P, Laitinen H, Palomäki P, Garbarg-Chenon A, Ranki A et al. Detection and differentiation of human parvovirus variants by commercial quantitative real-time PCR tests. J Clin Microbiol 2004; 42: 2013-2019. (Pubitemid 38637816)
51. Kantola K, Sadeghi M, Antikainen J, Kirveskari J, Delwart E, Hedman K et al. Realtime quantitative PCR detection of four human bocaviruses. J Clin Microbiol 2010; 48: 4044-4050.
52. Väisänen E, Lahtinen A, Hedman K, Sö derlund-Venermo M. Real-time PCR assay for detection, differentiation and quantification of three genotypes of human parvovirus 4 (submitted).
53. Zaki ME, Ashray RE. Clinical and haematological study for parvovirus b19 infection in children with acute leukemia. Int J Lab Hematol 2010; 32: 159-166.
54. Soliman O-S, Abd E-AHHM, El-Ashry R, Zaghloul MH, Kora B. Parvovirus B19 infection in pediatric oncology patients: diagnostic value of clinical and serologic parameters compared with nested PCR. J Pediatr Hematol Oncol 2009; 31: 173-176.
55. Sö derlund M, Ruutu P, Ruutu T, Asikainen K, Franssila R, Hedman K. Primary and secondary infections by human parvovirus B19 following bone marrow transplantation: characterization by PCR and B-cell molecular immunology. Scand J Infect Dis 1997; 29: 129-135.
56. Azzi A, Fanci R, Ciappi S, Zakrzewska K, Bosi A. Human parvovirus B19 infection in bone marrow transplantation patients. Am J Hematol 1993; 44: 207-209. (Pubitemid 23295706)
57. Eid AJ, Brown RA, Patel R, Razonable RR. Parvovirus B19 infection after transplantation: a review of 98 cases. Clin Infect Dis 2006; 43: 40-48. (Pubitemid 43941646)
58. Lindblom A, Isa A, Norbeck O, Wolf S, Johansson B, Broliden K et al. Slow clearance of human parvovirus B19 viremia following acute infection. Clin Infect Dis 2005; 41: 1201-1203. (Pubitemid 41429486)
59. Hayakawa F, Imada K, Towatari M, Saito H. Life-threatening human parvovirus B19 infection transmitted by intravenous immune globulin. Br J Haematol 2002; 118: 1187-1189. (Pubitemid 35025990)
60. Behre G, Christopeit M. Parvovirus B19 infection as trigger of graft vs host disease. Eur J Haematol 2008; 81: 404.
61. Corcoran A, Doyle S. Advances in the biology, diagnosis and host-pathogen interactions of parvovirus B19. J Med Microbiol 2004; 53: 459-475. (Pubitemid 38803039)
62. Hourfar MK, Mayr-Wohlfart U, Themann A, Sireis W, Seifried E, Schrezenmeier M et al. Recipients potentially infected with parvovirus B19 by red blood cell products. Transfusion 2011; 50: 129-136.
63. Foot AB, Potter MN, Donaldson C, Cornish JM, Wallington TB, Oakhill A et al. Immune reconstitution after BMT in children. Bone Marrow Transplant 1993; 11: 7-13. (Pubitemid 23086840)
64. Meriluoto M, Hedman L, Tanner L, Simell V, Mäkinen M, Simell S et al. Association of human bocavirus 1 infection with respiratory disease in childhood follow-up study, Finland. Emerg Infect Dis 2012; 18: 264-271.
65. Schildgen O, Mü ller A, Allander T, Mackay IM, Vö lz S, Kupfer B et al. Human bocavirus: passenger or pathogen in acute respiratory tract infections. Clin Microbiol Rev 2008; 21: 291-304. (Pubitemid 351555509)
66. von Linstow ML, Høgh M, Høgh B. Clinical and epidemiologic characteristics of human bocavirus in Danish infants: results from a prospective birth cohort study. Pediatr Infect Dis J 2008; 27: 897-902.
67. Brieu N, Guyon G, Rodié re M, Segondy M, Foulongne V. Human bocavirus infection in children with respiratory tract disease. Pediatr Infect Dis J 2008; 27: 969-973.
68. Lehtoranta L, Sö derlund-Venermo M, Nokso-Koivisto J, Toivola H, Blomgren K, Hatakka K et al. Human bocavirus in the nasopharynx of otitis-prone children. Int J Pediatr Otorhinolaryngol 2012; 76: 206-211.